Paula Sowon Lee | Scholars@Duke

Paula Sowon Lee
Assistant Professor of Obstetrics and Gynecology

Current Appointments & Affiliations

Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2007
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2015

Contact Information

Box 3079 Med Ctr, Durham, NC 27710
DUMC Box 3079, Durham, NC 27710
paula.s.lee@duke.edu (919) 684-3765

Background
Education, Training, & Certifications
- Residency, Ob/Gyn, Duke University 2000 - 2004
- M.D., Tulane University 2000
Duke Appointment History
- Clinical Associate in the Department of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2006 - 2007
- Clinical Associate in the Department of Obstetrics and Gynecology, Obstetrics and Gynecology, Clinical Science Departments 2005 - 2006
Research
Selected Grants
- PP LNM 01 FILM awarded by Novadaq Technologies Inc. 2016 - 2021
- A Pilot Study on H.O.P.E: Helping Ovarian Cancer Patients Cope with Disease Recurrence awarded by Foundation for Women's Cancer 2014 - 2016
Publications & Artistic Works
Selected Publications
- Conference Papers
  - Natesan, D, Craciunescu, OI, Lee, PS, and Chino, JP. "FDG Positron Emission Tomography (PET)/Computed Tomography Characteristics of Vulvar Cancer: Posttreatment PET Correlates With Clinical Outcomes." October 1, 2016. Full Text Link to Item
  - Natesan, D, Craciunescu, OI, Lee, PS, and Chino, JP. "FDG Positron Emission Tomography (PET)/Computed Tomography Characteristics of Vulvar Cancer: Posttreatment PET Correlates With Clinical Outcomes." October 1, 2016. Link to Item
  - Ehrisman, JA, Abbott, S, Harmon, Z, Secord, AA, Berchuck, A, Lee, PS, Valea, FA, Broadwater, G, Li, X, Havrilesky, LJ, and Hall, A. "Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-Grade Endometrial Cancer." February 2016. Link to Item
  - Teoh, D, Lowery, WJ, Jiang, X, Ehrisman, J, Halvorson, P, Broadwater, G, Bentley, R, Secord, AA, Sobolewski, C, Berchuck, A, Havrilesky, LJ, Valea, FA, and Lee, PS. "Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial." February 2015. Full Text
  - Havrilesky, LJ, Secord, AA, Ehrisman, JA, Berchuck, A, Valea, FA, Lee, PS, Gaillard, S, Celia, D, Weinfurt, K, Abernethy, AP, and Reed, SD. "Relative influence of factors determining a woman's preference for treatment options in ovarian cancer." May 20, 2014. Link to Item
  - Havrilesky, L, Secord, A, Ehrisman, J, Berchuck, A, Valea, F, Lee, P, Cella, D, Weinfurt, K, Abernethy, A, and Reed, S. "Relative Influence of Factors Determining a Woman’s Preference for Treatment Options in Ovarian Cancer: A Discrete Choice Experiment." May 2014. Full Text
  - Lee, PS, Teaberry, V, Bland, AE, Huang, Z, Secord, AA, Berchuck, A, and Murphy, SK. "MAL, a gene associated with survival in epithelial ovarian cancer, is epigenetically regulated." March 2008. Link to Item
  - Rubatt, JM, Darcy, KM, Hutson, A, Bean, SM, Havrilesky, LJ, Lee, PS, Grace, LA, Berchuck, A, and Secord, AA. "Prognostic relevance of microvessel density in previously untreated, advanced-stage epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study." March 2008. Link to Item
- Journal Articles
  - Lim, SL, Moss, HA, Secord, AA, Lee, PS, Havrilesky, LJ, and Davidson, BA. "Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis." Gynecologic Oncology (September 23, 2018). Full Text
  - Davidson, BA, Ehrisman, J, Abbott, S, Harmon, Z, Secord, AA, Berchuck, A, Lee, PS, Valea, FA, Li, X, Havrilesky, LJ, and Hall, AHS. "Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer." International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists 37, no. 3 (May 2018): 252-255. Full Text
  - Foote, J, Lopez-Acevedo, M, Samsa, G, Lee, PS, Kamal, AH, Alvarez Secord, A, and Havrilesky, LJ. "Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 28, no. 2 (February 2018): 302-307. Full Text
  - Tanner, E, Puechl, A, Levinson, K, Havrilesky, LJ, Sinno, A, Secord, AA, Fader, AN, and Lee, PS. "Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer." Gynecologic Oncology 147, no. 3 (December 2017): 535-540. Full Text
  - Foote, JR, Lopez-Acevedo, M, Buchanan, AH, Secord, AA, Lee, PS, Fountain, C, Myers, ER, Cohn, DE, Reed, SD, and Havrilesky, LJ. "Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer." Journal of Oncology Practice 13, no. 2 (February 2017): e120-e129. Full Text
  - Foote, JR, Lopez-Acevedo, M, Buchanan, AH, Secord, AA, Lee, PS, Fountain, C, Myers, ER, Cohn, DE, Reed, SD, and Havrilesky, LJ. "Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer." Journal of Oncology Practice 13, no. 2 (February 2017): e120-e129. Full Text
  - Giattino, CM, Gardner, JE, Sbahi, FM, Roberts, KC, Cooter, M, Moretti, E, Browndyke, JN, Mathew, JP, Woldorff, MG, Berger, M, and MADCO-PC Investigators, . "Intraoperative Frontal Alpha-Band Power Correlates with Preoperative Neurocognitive Function in Older Adults." Frontiers in Systems Neuroscience 11 (January 2017): 24-null. Full Text Open Access Copy
  - Lee, PS, Kempner, S, Miller, M, Dominguez, J, Grotegut, C, Ehrisman, J, Previs, R, Havrilesky, LJ, Broadwater, G, Ellestad, SC, and Secord, AA. "Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes." Gynecologic Oncology Research and Practice 4 (January 2017): 11-null. Full Text Open Access Copy
  - Natesan, D, Craciunescu, OI, Lee, PS, and Chino, JP. "FDG Positron Emission Tomography (PET)/Computed Tomography Characteristics of Vulvar Cancer: Posttreatment PET Correlates With Clinical Outcomes." International journal of radiation oncology, biology, physics 96, no. 2S (October 2016): S52-S53. Full Text
  - Ehrisman, J, Secord, AA, Berchuck, A, Lee, PS, Di Santo, N, Lopez-Acevedo, M, Broadwater, G, Valea, FA, and Havrilesky, LJ. "Performance of sentinel lymph node biopsy in high-risk endometrial cancer." Gynecologic oncology reports 17 (August 2016): 69-71. Full Text
  - Fox, KA, Shamshirsaz, AA, Carusi, D, Secord, AA, Lee, P, Turan, OM, Huls, C, Abuhamad, A, Simhan, H, Barton, J, Wright, J, Silver, R, and Belfort, MA. "Conservative management of morbidly adherent placenta: expert review." American Journal of Obstetrics and Gynecology 213, no. 6 (December 2015): 755-760. (Review) Full Text
  - Rimel, BJ, Burke, WM, Higgins, RV, Lee, PS, Lutman, CV, and Parker, L. "Improving Quality and Decreasing Cost in Gynecologic Oncology Care. Society of Gynecologic Oncology Recommendations for Clinical Practice." Obstetrical & Gynecological Survey 70, no. 9 (September 2015): 570-571. Full Text
  - Konecny, GE, Finkler, N, Garcia, AA, Lorusso, D, Lee, PS, Rocconi, RP, Fong, PC, Squires, M, Mishra, K, Upalawanna, A, Wang, Y, and Kristeleit, R. "Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study." The Lancet. Oncology 16, no. 6 (June 2015): 686-694. Full Text
  - Landrum, LM, Blank, S, Chen, L-M, Duska, L, Bae-Jump, V, Lee, PS, Levine, L, McCourt, C, Moore, KN, and Urban, RR. "Comprehensive care in gynecologic oncology: The importance of palliative care." Gynecologic oncology 137, no. 2 (May 2015): 193-202. Full Text
  - Rimel, BJ, Burke, WM, Higgins, RV, Lee, PS, Lutman, CV, and Parker, L. "Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice." Gynecologic oncology 137, no. 2 (May 2015): 280-284. Full Text
  - Teoh, D, Lowery, WJ, Jiang, X, Ehrisman, J, Halvorson, P, Broadwater, G, Bentley, R, Secord, AA, Sobolewski, C, Berchuck, A, Havrilesky, LJ, Valea, FA, and Lee, PS. "Vaginal Cuff Thermal Injury by Mode of Colpotomy at Total Laparoscopic Hysterectomy: A Randomized Clinical Trial." JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY 22, no. 2 (February 2015): 227-233. Full Text Link to Item
  - Landrum, LM, Blank, S, Chen, LM, Duska, L, Bae-Jump, V, Lee, PS, Levine, L, McCourt, C, Moore, KN, and Urban, RR. "Comprehensive care in gynecologic oncology: The importance of palliative care." Gynecologic Oncology 137, no. 2 (January 1, 2015): 193-202. Full Text
  - Rimel, BJ, Burke, WM, Higgins, RV, Lee, PS, Lutman, CV, and Parker, L. "Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice." Gynecologic Oncology 137, no. 2 (January 1, 2015): 280-284. Full Text
  - Campos, SM, Brady, WE, Moxley, KM, O'Cearbhaill, RE, Lee, PS, DiSilvestro, PA, Rotmensch, J, Rose, P, Thaker, PH, O'Malley, DM, ParvizHanjani, , Zuna, RE, and Hensley, ML. "Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537–541]." Gynecologic Oncology 135, no. 3 (December 2014): 624-624. Full Text
  - Havrilesky, LJ, Alvarez Secord, A, Ehrisman, JA, Berchuck, A, Valea, FA, Lee, PS, Gaillard, SL, Samsa, GP, Cella, D, Weinfurt, KP, Abernethy, AP, and Reed, SD. "Patient preferences in advanced or recurrent ovarian cancer." Cancer 120, no. 23 (December 2014): 3651-3659. Full Text
  - Powell, MA, Sill, MW, Goodfellow, PJ, Benbrook, DM, Lankes, HA, Leslie, KK, Jeske, Y, Mannel, RS, Spillman, MA, Lee, PS, Hoffman, JS, McMeekin, DS, and Pollock, PM. "A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study." Gynecologic Oncology 135, no. 1 (October 2014): 38-43. Full Text
  - Powell, MA, Sill, MW, Goodfellow, PJ, Benbrook, DM, Lankes, HA, Leslie, KK, Jeske, Y, Mannel, RS, Spillman, MA, Lee, PS, Hoffman, JS, McMeekin, DS, and Pollock, PM. "A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study." Gynecologic Oncology 135, no. 1 (October 1, 2014): 38-43. Full Text
  - Campos, SM, Brady, WE, Moxley, KM, O'Cearbhaill, RE, Lee, PS, DiSilvestro, PA, Rotmensch, J, Rose, PG, Thaker, PH, O'Malley, DM, Hanjani, P, Zuna, RE, and Hensley, ML. "A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study." Gynecologic oncology 133, no. 3 (June 2014): 537-541. Full Text
  - Lee, PS, and Secord, AA. "Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway." Cancer Treat Rev 40, no. 4 (May 2014): 507-512. (Review) Full Text Link to Item
  - Lee, PS, and Secord, AA. "Targeting molecular pathways in endometrial cancer: A focus on the FGFR pathway." Cancer Treatment Reviews 40, no. 4 (May 1, 2014): 507-512. (Review) Full Text
  - Zhang, C, Havrilesky, LJ, Broadwater, G, Di Santo, N, Ehrisman, JA, Lee, PS, Berchuck, A, Alvarez Secord, A, Bean, S, Bentley, RC, and Valea, FA. "Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients." Gynecologic oncology 133, no. 2 (May 2014): 211-215. Full Text
  - Zhang, C, Havrilesky, LJ, Broadwater, G, Di Santo, N, Ehrisman, JA, Lee, PS, Berchuck, A, Alvarez Secord, A, Bean, S, Bentley, RC, and Valea, FA. "Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: A single institution study of 458 patients." Gynecologic Oncology 133, no. 2 (May 2014): 211-215. Full Text
  - Campos, SM, Brady, WE, Moxley, KM, O'Cearbhaill, RE, Lee, PS, Disilvestro, PA, Rotmensch, J, Rose, PG, Thaker, PH, O'Malley, DM, Hanjani, P, Zuna, RE, and Hensley, ML. "A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study." Gynecologic Oncology 133, no. 3 (January 1, 2014): 537-541. Full Text
  - Havrilesky, LJ, Secord, AA, Ehrisman, JA, Berchuck, A, Valea, FA, Lee, PS, Gaillard, SL, Samsa, GP, Cella, D, Weinfurt, KP, Abernethy, AP, and Reed, SD. "Patient preferences in advanced or recurrent ovarian cancer." Cancer 120, no. 23 (January 1, 2014): 3651-3659. Full Text
  - Lee, PS, and Secord, AA. "Targeting molecular pathways in endometrial cancer: A focus on the FGFR pathway." Cancer Treatment Reviews 40, no. 4 (2014): 507-512.
  - Lopez-Acevedo, M, Lowery, WJ, Lowery, AW, Lee, PS, and Havrilesky, LJ. "Palliative and hospice care in gynecologic cancer: a review." Gynecol Oncol 131, no. 1 (October 2013): 215-221. (Review) Full Text Link to Item
  - Lowery, WJ, Lowery, AW, Barnett, JC, Lopez-Acevedo, M, Lee, PS, Secord, AA, and Havrilesky, L. "Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer." Gynecol Oncol 130, no. 3 (September 2013): 426-430. Full Text Link to Item
  - Lopez-Acevedo, M, Havrilesky, LJ, Broadwater, G, Kamal, AH, Abernethy, AP, Berchuck, A, Alvarez Secord, A, Tulsky, JA, Valea, F, and Lee, PS. "Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer." Gynecologic Oncology 130, no. 1 (July 2013): 156-161. Full Text
  - Lopez-Acevedo, M, Havrilesky, LJ, Broadwater, G, Kamal, AH, Abernethy, AP, Berchuck, A, Secord, AA, Tulsky, JA, Valea, F, and Lee, PS. "Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer." Gynecologic Oncology 130, no. 1 (2013): 156-161. Full Text
  - Lopez-Acevedo, M, Lowery, WJ, Lowery, AW, Lee, PS, and Havrilesky, LJ. "Palliative and hospice care in gynecologic cancer: A review." Gynecologic Oncology 131, no. 1 (2013): 215-221. Full Text
  - Lowery, WJ, Lowery, AW, Barnett, JC, Lopez-Acevedo, M, Lee, PS, Secord, AA, and Havrilesky, L. "Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer." Gynecologic Oncology 130, no. 3 (2013): 426-430. Full Text
  - Turner, T, Secord, AA, Lowery, WJ, Sfakianos, G, and Lee, PS. "Metastatic adenocarcinoma after laparoscopic supracervical hysterectomy with morcellation: A case report." Gynecologic Oncology Case Reports 5 (2013): 19-21. Full Text
  - Lopez-Acevedo, M, Zhang, C, Secord, AA, Lee, PS, Havrilesky, LJ, and Berchuck, A. "Predictors of failure to perform pelvic peritoneal cytology in endometrial cancer staging surgery." JOURNAL OF CLINICAL ONCOLOGY 30, no. 34 (December 1, 2012). Full Text Link to Item
  - Zhang, C, Secord, AA, Lee, PS, Havrilesky, LJ, and Berchuck, A. "Predictors of failure to perform pelvic peritoneal cytology in endometrial cancer staging surgery." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 30, no. 34_suppl (December 2012): 201-.
  - Secord, AA, Teoh, DK, Barry, WT, Yu, M, Broadwater, G, Havrilesky, LJ, Lee, PS, Berchuck, A, Lancaster, J, and Wenham, RM. "A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 18, no. 19 (October 2012): 5489-5498. Full Text
  - Alvarez Secord, A, Darcy, KM, Hutson, A, Huang, Z, Lee, PS, Jewell, EL, Havrilesky, LJ, Markman, M, Muggia, F, and Murphy, SK. "The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study." Gynecol Oncol 123, no. 2 (November 2011): 314-319. Full Text Link to Item
  - Teoh, D, Berchuck, A, Alvarez Secord, A, Lee, PS, Lowery, WJ, Sfakianos, GP, Valea, FA, Myers, ER, and Havrilesky, LJ. "Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer." Gynecol Oncol 122, no. 3 (September 2011): 467-472. Full Text Link to Item
  - Barnett, JC, Havrilesky, LJ, Bondurant, AE, Fleming, ND, Lee, PS, Secord, AA, Berchuck, A, and Valea, FA. "Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer." Am J Obstet Gynecol 205, no. 2 (August 2011): 143.e1-143.e6. Full Text Link to Item
  - Bernardini, MQ, Baba, T, Lee, PS, Barnett, JC, Sfakianos, GP, Secord, AA, Murphy, SK, Iversen, E, Marks, JR, and Berchuck, A. "Expression signatures of TP53 mutations in serous ovarian cancers." Bmc Cancer 10 (May 26, 2010): 237-null. Full Text Open Access Copy
  - Lee, PS, Teaberry, VS, Bland, AE, Huang, Z, Whitaker, RS, Baba, T, Fujii, S, Secord, AA, Berchuck, A, and Murphy, SK. "Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer." Int J Cancer 126, no. 6 (March 15, 2010): 1378-1389. Full Text Link to Item
  - Jewell, EL, Darcy, KM, Hutson, A, Lee, PS, Havrilesky, LJ, Grace, LA, Berchuck, A, and Secord, AA. "Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study." Gynecologic Oncology 115, no. 3 (December 2009): 424-429. Full Text
  - Lee, PS, Bland, A, Valea, FA, Havrilesky, LJ, Berchuck, A, and Secord, AA. "Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program." Jsls : Journal of the Society of Laparoendoscopic Surgeons 13, no. 4 (October 2009): 467-472. Full Text
  - Horne, HN, Lee, PS, Murphy, SK, Alonso, MA, Olson, JA, and Marks, JR. "Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy." Molecular Cancer Research : Mcr 7, no. 2 (February 10, 2009): 199-209. Full Text
  - Matsumura, N, Huang, Z, Baba, T, Lee, PS, Barnett, JC, Mori, S, Chang, JT, Kuo, W-L, Gusberg, AH, Whitaker, RS, Gray, JW, Fujii, S, Berchuck, A, and Murphy, SK. "Yin yang 1 modulates taxane response in epithelial ovarian cancer." Molecular Cancer Research : Mcr 7, no. 2 (February 10, 2009): 210-220. Full Text
  - Bland, AE, Calingaert, B, Secord, AA, Lee, PS, Valea, FA, Berchuck, A, Soper, JT, and Havrilesky, L. "Relationship between tamoxifen use and high risk endometrial cancer histologic types." Gynecol Oncol 112, no. 1 (January 2009): 150-154. Full Text Link to Item
  - Lee, PS, Bakelaar, R, Fitpatrick, CB, Ellestad, SC, Havrilesky, LJ, and Alvarez Secord, A. "Medical and surgical treatment of placenta percreta to optimize bladder preservation." Obstet Gynecol 112, no. 2 Pt 2 (August 2008): 421-424. Full Text Link to Item
  - Barnett, JC, Bland, A, Whitaker, R, Calingaert, B, Bentley, RC, Lee, PS, Moorman, PC, Schildkraut, JM, and Berchuck, A. "The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S125-S125. Link to Item
  - Schildkraut, JM, Moorman, PG, Bland, AE, Halabi, S, Calingaert, B, Whitaker, R, Lee, PS, Elkins-Williams, T, Bentley, RC, Marks, JR, and Berchuck, A. "Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup." Cancer Epidemiol Biomarkers Prev 17, no. 3 (March 2008): 585-593. Full Text Link to Item
  - Secord, AA, Darcy, KM, Hutson, A, Lee, PS, Havrilesky, LJ, Grace, LA, Berchuck, A, and Gynecologic Oncology Group study, . "Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study." Gynecol Oncol 106, no. 1 (July 2007): 221-232. Full Text Link to Item
  - Gynecologic Oncology Group, , Secord, AA, Lee, PS, Darcy, KM, Havrilesky, LJ, Grace, LA, Marks, JR, and Berchuck, A. "Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study." Gynecologic Oncology 101, no. 3 (June 2006): 390-397. Full Text
  - Clarke-Pearson, DL, Spillman, MA, Lutman, CV, and Lee, PS. "Preoperative evaluation and postoperative management." Clinical Gynecology (2006): 233-248. Full Text
  - Berchuck, A, Iversen, ES, Lancaster, JM, Pittman, J, Luo, J, Lee, P, Murphy, S, Dressman, HK, Febbo, PG, West, M, Nevins, JR, and Marks, JR. "Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers." Clin Cancer Res 11, no. 10 (May 15, 2005): 3686-3696. Full Text Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Conference Papers

Journal Articles